FKSG2 Antikörper (AA 1-139) (FITC)
-
- Target Alle FKSG2 Produkte
- FKSG2 (Tumor Protein, Translationally-Controlled 1 Pseudogene (FKSG2))
-
Bindungsspezifität
- AA 1-139
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser FKSG2 Antikörper ist konjugiert mit FITC
- Applikation
- Bitte anfragen
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Putative translationally-controlled tumor protein-like protein TPT1P8 protein (1-139AA)
- Isotyp
- IgG
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- FKSG2 (Tumor Protein, Translationally-Controlled 1 Pseudogene (FKSG2))
- Andere Bezeichnung
- TPT1P8 (FKSG2 Produkte)
- Synonyme
- FKSG2 antikoerper, tumor protein, translationally-controlled 1 pseudogene 8 antikoerper, TPT1P8 antikoerper
- Hintergrund
-
Background: cytoplasm, calcium ion binding, microtubule binding, cell differentiation
Aliases: TPT1P8 antibody, FKSG2 antibody, Putative translationally-controlled tumor protein-like protein TPT1P8 antibody, Putative apoptosis inhibitor FKSG2 antibody
- UniProt
- Q9HAU6
-